Analytical Data
-
Gene name
EPGN
- Application
-
Alternative Names
EPGN;Epigen
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q6UW88-2
-
Expression Region
24-95aa
-
AA Sequence
AVTVTPPITA QQADNIEGPI ALKFSHLCLE DHNSYCINGA CAFHHELEKA ICRCFTGYTG ERCEHLTLTS YA
-
Molecular Weight
8 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The EPGN (epidermal growth factor-containing protein) gene encodes a secreted protein that possesses epidermal growth factor (EGF)-like domains, suggesting its involvement in various biological processes, particularly in cell proliferation and differentiation. Research on EPGN has gained momentum due to its potential implications in developmental biology and oncology. Studies have shown that EPGN may play a crucial role in wound healing and tissue repair, acting as a growth factor that stimulates cellular responses. Furthermore, altered expression levels of EPGN have been linked to several cancers, making it a subject of interest in cancer research and therapy. Understanding EPGN's structure and function, particularly through recombinant protein studies, can provide insights into its biological roles and therapeutic potential, as well as its interactions with other signaling pathways. This research could pave the way for novel diagnostic and therapeutic approaches targeting EPGN-related pathways in diseases characterized by aberrant growth and repair mechanisms.
